A significant breakthrough in vaccine development has been achieved by a collaboration between the Ragon Institute and the Jameel Clinic at MIT, as they unveil MUNIS, a deep learning tool designed to accurately predict CD8+ T cell epitopes. This innovative tool promises to accelerate vaccine
Tuberculosis (TB) remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant challenge to global health. Recent advancements in TB treatment, particularly for drug-resistant forms, offer new hope. This article explores the potential of new drug
Imagine a future where birth injuries, facial defects, and other cartilage-related conditions could be treated effectively and efficiently with a novel tissue that combines softness, elasticity, and stability. This future has moved significantly closer to reality with the discovery of a new
Recent research led by scientists at Scripps Research has unveiled groundbreaking insights into the structure and behavior of the protein transthyretin, which could have significant implications for the treatment of transthyretin amyloidosis (ATTR). This disease, marked by the misfolding of
The increasing prevalence of Coxsackievirus A6 (CVA6) as a major causative agent for Hand, Foot, and Mouth Disease (HFMD) worldwide necessitates the development of an effective vaccine, especially since there is currently no vaccine available against CVA6 infections. CVA6 infections pose a
The biopharma industry stands at a transformative juncture as it reflects on the achievements of the past year and anticipates the evolving client requirements that will shape 2025 and beyond. Key insights from Subodh Deshmukh, CEO of Aragen Bioscience, highlight the crucial areas of focus for
